Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11777
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRatković, Zoran-
dc.contributor.authorMuškinja, Jovana-
dc.contributor.authorBurmudz̃ija A.-
dc.contributor.authorRanković B.-
dc.contributor.authorKosanic, Marijana-
dc.contributor.authorBogdanovic, Goran A.-
dc.contributor.authorSimovic Markovic, Bojana-
dc.contributor.authorNikolić A.-
dc.contributor.authorArsenijevic, Nebojsa-
dc.contributor.authorCrossed D Signorcrossed D Signevic S.-
dc.contributor.authorVukicevic R.-
dc.date.accessioned2021-04-20T19:12:14Z-
dc.date.available2021-04-20T19:12:14Z-
dc.date.issued2016-
dc.identifier.issn0022-2860-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/11777-
dc.description.abstract© 2016 Elsevier B.V. All rights reserved. A small series of 1-acetyl-5-aryl-4,5-dihydro-1H-pyrazoles (aryl = 4-hydroxy-3-methoxyphenyl and 4-alkoxy-3-methoxyphenyl) was prepared, starting from 4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one, dehydrozingerone, and its alkyl derivatives. Their in vitro cytotoxic activity against some cancer cell lines was tested, showing significant anticancer activity. All the new compounds were well characterized by IR, 1H, 13C NMR and ESI-MS spectroscopy and physical data, whereas structures of two of them were determined by single crystal X-ray analysis.-
dc.rightsrestrictedAccess-
dc.sourceJournal of Molecular Structure-
dc.titleDehydrozingerone based 1-acetyl-5-aryl-4,5-dihydro-1H-pyrazoles: Synthesis, characterization and anticancer activity-
dc.typearticle-
dc.identifier.doi10.1016/j.molstruc.2015.12.079-
dc.identifier.scopus2-s2.0-84953455358-
Appears in Collections:Faculty of Medical Sciences, Kragujevac
Faculty of Science, Kragujevac
Institute for Information Technologies, Kragujevac

Page views(s)

307

Downloads(s)

11

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.